BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.236
EU - Europa 2.017
AS - Asia 1.543
SA - Sud America 245
AF - Africa 28
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 7.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.181
IT - Italia 592
CN - Cina 476
SG - Singapore 468
GB - Regno Unito 339
IE - Irlanda 315
HK - Hong Kong 205
BR - Brasile 195
DE - Germania 171
SE - Svezia 147
VN - Vietnam 92
RU - Federazione Russa 84
FR - Francia 77
FI - Finlandia 75
ID - Indonesia 55
TR - Turchia 45
IN - India 39
CA - Canada 36
JP - Giappone 34
UA - Ucraina 31
BE - Belgio 27
KR - Corea 27
BG - Bulgaria 24
LT - Lituania 23
NL - Olanda 22
PL - Polonia 20
AR - Argentina 19
TW - Taiwan 18
MY - Malesia 15
CZ - Repubblica Ceca 14
ES - Italia 13
IR - Iran 13
MX - Messico 12
CO - Colombia 11
AT - Austria 10
AU - Australia 10
BD - Bangladesh 9
EU - Europa 9
AL - Albania 8
IQ - Iraq 7
VE - Venezuela 7
ZA - Sudafrica 7
EC - Ecuador 6
CL - Cile 5
MT - Malta 5
SA - Arabia Saudita 5
IL - Israele 4
MA - Marocco 4
RO - Romania 4
TH - Thailandia 4
CR - Costa Rica 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
NO - Norvegia 3
PH - Filippine 3
PK - Pakistan 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
DJ - Gibuti 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 7.091
Salva come PNG Salva come JPEG
Città #
Santa Clara 386
Ashburn 354
Dublin 314
Chandler 310
Singapore 294
Fairfield 219
Hong Kong 198
Southend 150
Dallas 146
Hefei 142
Nyköping 112
Woodbridge 112
Ann Arbor 99
Seattle 95
London 91
Wilmington 89
Beijing 84
Houston 79
Cambridge 72
New York 71
Modena 68
Helsinki 64
Los Angeles 61
Dearborn 59
The Dalles 44
Jakarta 43
Munich 40
Jacksonville 38
Bologna 37
Milan 37
Moscow 36
Fremont 34
Shanghai 33
Ho Chi Minh City 29
Council Bluffs 28
San Diego 28
São Paulo 28
Redwood City 27
Chicago 26
Seoul 26
Sofia 24
Princeton 23
Brussels 22
Rome 21
Lauterbourg 20
San Giuliano Milanese 19
Hanoi 18
Reggio Emilia 18
Tokyo 18
Bremen 17
Dong Ket 17
Paris 16
Eugene 15
Parma 15
Redondo Beach 15
Brooklyn 14
Falls Church 14
Portsmouth 14
Warsaw 14
Columbus 12
Orem 12
Buffalo 11
Denver 11
Düsseldorf 11
Guangzhou 11
New Taipei 11
San Jose 11
Frankfurt am Main 10
Izmir 10
Nuremberg 10
Phoenix 10
Toronto 10
Poplar 9
Brno 8
Caprarola 8
Genoa 8
Glasgow 8
Kent 8
Norwalk 7
Santorso 7
Sassuolo 7
Shinjuku 7
Stockholm 7
Venezia 7
Boardman 6
Castelvetrano 6
Chennai 6
Des Moines 6
Florence 6
Istanbul 6
Melbourne 6
Montreal 6
Salt Lake City 6
Taipei 6
Turku 6
Vernon 6
Amsterdam 5
Aydin 5
Bomporto 5
Changchun 5
Totale 4.860
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 382
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 331
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 323
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 321
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 305
A concise review of lenalidomide therapy for follicular lymphoma 299
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 298
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 295
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 281
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 265
The evolving role of microsatellite instability in colorectal cancer: A review 259
Breast Location for De Novo Extramedullary Myeloid Sarcoma 239
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 231
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 223
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 222
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 215
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 213
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 212
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 210
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 201
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 192
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 182
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 173
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 172
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 169
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 169
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 153
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 143
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 129
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 121
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 111
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 105
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 5
Totale 7.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 60 19 58 32 42 35 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20261.648 238 98 317 331 447 217 0 0 0 0 0 0
Totale 7.149